SCHEMBL20047249

SCHEMBL20047249

CC(S)C1OC(=O)CC1=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17774455 0.82 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL13434962 0.82 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL2650942 0.64
SCHEMBL5924132 0.64
SCHEMBL27035890 0.64 CA1 (0.35) SMN1; SMN2
SCHEMBL3821916 0.62 SMN1; SMN2 (0.36) SMN1; SMN2
SCHEMBL13105435 0.61 SMN1; SMN2 (0.40) SMN1; SMN2
SCHEMBL13120290 0.61 SMN1; SMN2 (0.40) SMN1; SMN2
SCHEMBL12601231 0.59 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL5924334 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018065962-A1 SUBSTITUTED PYRROLIDINES AND THEIR USE IN THE TREATMENT OF CYSTIC FIIBROSIS AbbVie S.à.r.l. (LU) 2018-04-12 WO disclosed